147 related articles for article (PubMed ID: 25491784)
1. A Calcitonin-Negative Neuroendocrine Tumor Derived from Follicular Lesions of the Thyroid.
Kim GY; Park CY; Cho CH; Park JS; Jung ED; Jeon EJ
Endocrinol Metab (Seoul); 2015 Jun; 30(2):221-5. PubMed ID: 25491784
[TBL] [Abstract][Full Text] [Related]
2. Calcitonin-negative neuroendocrine tumor of the thyroid: a distinct clinical entity.
Chernyavsky VS; Farghani S; Davidov T; Ma L; Barnard N; Amorosa LF; Trooskin SZ
Thyroid; 2011 Feb; 21(2):193-6. PubMed ID: 21275766
[TBL] [Abstract][Full Text] [Related]
3. C-cell-derived calcitonin-free neuroendocrine carcinoma of the thyroid: the diagnostic importance of CGRP immunoreactivity.
Nakazawa T; Cameselle-Teijeiro J; Vinagre J; Soares P; Rousseau E; Eloy C; Sobrinho-Simões M
Int J Surg Pathol; 2014 Sep; 22(6):530-5. PubMed ID: 24599901
[TBL] [Abstract][Full Text] [Related]
4. Calcitonin-Negative Neuroendocrine Tumor of the Thyroid.
Parmer M; Milan S; Torabi A
Int J Surg Pathol; 2017 Apr; 25(2):191-194. PubMed ID: 27658647
[TBL] [Abstract][Full Text] [Related]
5. Primary high-grade calcitonin-negative neuroendocrine carcinoma of the thyroid: a very rare cancer.
Chorny JA; Orrego JJ; Cameselle-Teijeiro JM
Endocrinol Diabetes Metab Case Rep; 2018; 2018():. PubMed ID: 29692901
[TBL] [Abstract][Full Text] [Related]
6. A Calcitonin Non-producing Neuroendocrine Tumor of the Thyroid Gland.
Kasajima A; Cameselle-Teijeiro J; Loidi L; Takahashi Y; Nakashima N; Sato S; Fujishima F; Watanabe M; Nakazawa T; Naganuma H; Kondo T; Kato R; Sasano H
Endocr Pathol; 2016 Dec; 27(4):325-331. PubMed ID: 26860935
[TBL] [Abstract][Full Text] [Related]
7. False-positive staining of thyroglobulin distinguished from mixed medullary and follicular thyroid carcinoma by duplex in situ hybridization.
Takeshima K; Ariyasu H; Uraki S; Morita S; Furukawa Y; Inaba H; Iwakura H; Doi A; Warigaya K; Murata SI; Enomoto K; Hotomi M; Akamizu T
Endocr J; 2020 Oct; 67(10):1007-1017. PubMed ID: 32522910
[TBL] [Abstract][Full Text] [Related]
8. Expression of v-Ha-ras driven by the calcitonin/calcitonin gene-related peptide promoter: a novel transgenic murine model for medullary thyroid carcinoma.
Johnston D; Hatzis D; Sunday ME
Oncogene; 1998 Jan; 16(2):167-77. PubMed ID: 9464534
[TBL] [Abstract][Full Text] [Related]
9. Medullary thyroid carcinoma diagnosed with liquid-based cytology and immunocytochemistry.
Nikas IP; Kazamias G; Vrontaki M; Rapti AS; Mastorakis E
J Immunoassay Immunochem; 2022 Sep; 43(5):502-515. PubMed ID: 35475413
[TBL] [Abstract][Full Text] [Related]
10. Case Report: A Challenging Clinical Problem of Calcitonin-Negative Medullary Thyroid Cancer Diagnosis and Surveillance.
Rafaey W; Munir Alvi A; Siddiqi AI; Shafiq W; Irfan H
Cureus; 2022 Nov; 14(11):e32088. PubMed ID: 36600874
[TBL] [Abstract][Full Text] [Related]
11. Serum calcitonin negative medullary thyroid carcinoma.
Sand M; Gelos M; Sand D; Bechara FG; Bonhag G; Welsing E; Mann B
World J Surg Oncol; 2006 Dec; 4():97. PubMed ID: 17184544
[TBL] [Abstract][Full Text] [Related]
12. Other markers of medullary thyroid cancer, not only calcitonin.
Censi S; Manso J; Mian C
Eur J Endocrinol; 2023 Jan; 188(1):. PubMed ID: 36651167
[TBL] [Abstract][Full Text] [Related]
13. Calcitonin-negative neuroendocrine tumor of thyroid gland mimicking anaplastic carcinoma: an unusual entity.
Ismi O; Arpaci RB; Berkesoglu M; Dag A; Sezer E; Bal KK; Vayısoğlu Y
Gland Surg; 2015 Aug; 4(4):344-9. PubMed ID: 26312221
[TBL] [Abstract][Full Text] [Related]
14. Medullary thyroid carcinomas express chromogranin A and a novel neuroendocrine protein recognized by monoclonal antibody HISL-19.
Deftos LJ; Woloszczuk W; Krisch I; Horvat G; Ulrich W; Neuhold N; Braun O; Reiner A; Srikanta S; Krisch K
Am J Med; 1988 Dec; 85(6):780-4. PubMed ID: 3195602
[TBL] [Abstract][Full Text] [Related]
15. Case report of a neuroendocrine tumor of the thyroid gland with limited calcitonin expression: a diagnostic challenge.
Sukpanich R; Khanafshar E; Suh I; Gosnell J
AME Case Rep; 2019; 3():12. PubMed ID: 31231713
[TBL] [Abstract][Full Text] [Related]
16. Significance of chromogranin A and synaptophysin in medullary thyroid carcinoma.
Tomita T
Bosn J Basic Med Sci; 2021 Oct; 21(5):535-541. PubMed ID: 33485291
[TBL] [Abstract][Full Text] [Related]
17. Calcitonin-negative primary neuroendocrine tumor of the thyroid (nonmedullary) in a dog.
Arias EA; Castillo VA; Aristarain ME
Open Vet J; 2016; 6(3):223-227. PubMed ID: 27928520
[TBL] [Abstract][Full Text] [Related]
18. Predictive value of pentagastrin test for preoperative differential diagnosis between C-cell hyperplasia and medullary thyroid carcinoma in patients with moderately elevated basal calcitonin levels.
Milone F; Ramundo V; Chiofalo MG; Severino R; Paciolla I; Pezzullo L; Lombardi G; Colao A; Faggiano A
Clin Endocrinol (Oxf); 2010 Jul; 73(1):85-8. PubMed ID: 20039894
[TBL] [Abstract][Full Text] [Related]
19. Mixed follicular-medullary thyroid carcinoma: a case report.
Luboshitzky R; Dharan M
Diagn Cytopathol; 2004 Feb; 30(2):122-4. PubMed ID: 14755766
[TBL] [Abstract][Full Text] [Related]
20. Mixed medullary-follicular carcinoma of the thyroid.
Tohidi M; Pourbehi G; Bahmanyar M; Eghbali SS; Kalantar Hormozi M; Nabipour I
Case Rep Endocrinol; 2013; 2013():571692. PubMed ID: 24288632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
